Chimerix Stock Draws Heavy Retail Chatter After Landing Price-Target Hike On FDA Submission Plan For Cancer Drug
Following the news, JonesResearch raised its price target on Chimerix to $7 from $5 while maintaining a ‘Buy’ rating.
Stocktwits·10mo ago
More News
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits·11mo ago
These Three Stocks are Experiencing an Outbreak– Or a Breakout Depending How you Look at it
The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.
Sponsored·1y ago
Chimerix Board Changes: Machado Resigns, Kozin Appointed
The latest announcement is out from Chimerix (CMRX). Patrick Machado has announced his resignation from the Board of Directors of Chimerix, Inc., e...
TipRanks Financial Blog·2y ago
Chimerix Appoints Marc D. Kozin to Board of Directors
Veteran Industry Executive Brings More Than 35 Years of Corporate Strategy ExperienceDURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose...
Globe Newswire·2y ago
Chimerix (NASDAQ:CMRX) Raised to "Hold" at StockNews.com
StockNews.com upgraded shares of Chimerix (NASDAQ:CMRX Free Report) from a sell rating to a hold rating in a research report released on Monday.
Other research analysts also recently issued...
Zolmax·2y ago
Chimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Chimerix ( NASDAQ:CMRX ) Full Year 2023 Results Key Financial Results Net loss: US$82.1m (down by 148% from US$172.2m...
Simply Wall St·2y ago
Chimerix: Tackling A Strong Unmet Need With Promising Data
Chimerix: Tackling A Strong Unmet Need With Promising Data...
SeekingAlpha·2y ago
Chimerix files $250M mixed securities shelf
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
ONC201 ACTION Study Progressing; Reiterate Interim OS Data Expected in 2025, Final OS Data Expected in 2026 Phase 2 ONC201 Data Published in Peer-Reviewed Journal of Clinical Oncology $204...